A modification of the in vivo mixed lymphocyte reaction and rapamycin's effect in this model
- 30 September 1992
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 64 (3) , 242-247
- https://doi.org/10.1016/0090-1229(92)90206-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- FK506 and rapamycin: novel pharmacological probes of the immune responseTrends in Pharmacological Sciences, 1991
- PRODUCTION OF SYNERGISTIC BUT NONIDENTICAL MECHANISMS OF IMMUNOSUPPRESSION BY RAPAMYCIN AND CYCLOSPORINETransplantation, 1991
- Regulation of Alloreactivity in Vivo by a Soluble Form of the Interleukin-1 ReceptorScience, 1990
- T CELL ACTIVATION IN THE PRESENCE OF CYCLOSPORINE IN THREE IN VIVO ALLOGRAFT MODELS1Transplantation, 1988
- INDUCTION OF IL-2 RECEPTOR EXPRESSION IN VIVO RESPONSE TO ALLOGENEIC CELLSTransplantation, 1987
- Interleukin 1 and Interferon-γ: Cytokines that Provide Reciprocal Regulation of Macrophage and T Cell FunctionToxicologic Pathology, 1987
- Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts.The Journal of Experimental Medicine, 1987
- Disease modifying activity of HWA 486 on the development of SLE in MRL/1-miceInflammation Research, 1986
- T Cell-Dependent B Cell Lymphoproliferation and Activation Induced by the Drug DiphenylhydantoinPublished by Springer Nature ,1982
- Inhibition of the immune response by rapamycin, a new antifungal antibioticCanadian Journal of Physiology and Pharmacology, 1977